Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Fungal Allergenic Extract [EPC]
Geotrichum Candidum is a fungal allergenic extract used primarily for the diagnosis and treatment of mold-related allergies. It belongs to the class of non-standardized fungal allergenic extracts and is utilized in skin testing and subcutaneous immunotherapy.
Name
Geotrichum Candidum
Raw Name
GEOTRICHUM CANDIDUM
Category
Non-Standardized Fungal Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Geotrichum Candidum
Geotrichum Candidum is a fungal allergenic extract used primarily for the diagnosis and treatment of mold-related allergies. It belongs to the class of non-standardized fungal allergenic extracts and is utilized in skin testing and subcutaneous immunotherapy.
Detailed information about Geotrichum Candidum
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Geotrichum Candidum.
Geotrichum candidum is a yeast-like fungus that is ubiquitous in the environment, commonly found in soil, water, air, and various food products, particularly dairy. In the realm of clinical pharmacology, Geotrichum candidum is primarily utilized as a Non-Standardized Fungal Allergenic Extract [EPC]. This classification refers to biological products derived from fungal cultures that are used by allergists and immunologists to diagnose and treat hypersensitivity reactions. According to the FDA-approved labeling for allergenic extracts, these substances are intended to identify individuals whose symptoms are triggered by exposure to specific environmental molds and to provide a mechanism for desensitization through immunotherapy.
While Geotrichum candidum is categorized under the Penicillin-class Antibacterial [EPC] in some pharmacological databases, it is crucial to understand that in modern clinical practice, it is not used as an antibiotic to treat bacterial infections. This classification often reflects historical research into the secondary metabolites of fungi or potential cross-reactivity profiles rather than its primary therapeutic utility. Additionally, it is recognized as a Non-Standardized Food Allergenic Extract [EPC] due to its frequent presence in fermented foods like Camembert and Brie cheeses, where it contributes to the ripening process and flavor profile. For patients with specific food allergies, this extract helps clinicians determine if the fungus itself is the causative agent of an adverse reaction.
The therapeutic application of Geotrichum candidum extract is based on the principles of Type I hypersensitivity and immunological tolerance. When used for diagnostic purposes (skin testing), the extract is introduced into the epidermis or dermis. If the patient has pre-existing IgE antibodies specific to Geotrichum candidum antigens, these antibodies—which are bound to the surface of mast cells—will cross-link upon contact with the extract. This triggers degranulation, releasing histamine and other inflammatory mediators, resulting in a localized "wheal and flare" reaction (a raised bump surrounded by redness). This allows the healthcare provider to confirm a clinical allergy to the fungus.
When used for immunotherapy (allergy shots), the mechanism shifts toward the induction of immune tolerance. By administering gradually increasing doses of the Geotrichum candidum extract, the immune system is encouraged to shift its response from a Th2-dominated (allergic) pathway to a Th1-dominated or regulatory T-cell (Treg) pathway. This process leads to the production of IgG4 "blocking antibodies," which can intercept the allergen before it reaches the IgE on mast cells, thereby reducing the severity of allergic symptoms upon subsequent environmental exposure.
As a complex biological extract administered via skin prick or subcutaneous injection, the pharmacokinetic profile of Geotrichum candidum differs significantly from traditional oral or intravenous medications.
Geotrichum candidum extract is indicated for the following clinical applications:
Geotrichum candidum is typically available in the following forms:
> Important: Only your healthcare provider can determine if Geotrichum candidum is right for your specific condition. The selection of this extract must be based on a thorough clinical history and physical examination.
Dosage for Geotrichum candidum allergenic extract is highly individualized and is not measured in milligrams, but rather in Protein Nitrogen Units (PNU) or weight/volume (w/v) dilutions.
For skin prick testing, a concentrated extract (e.g., 1:10 or 1:20 w/v) is typically used. A single drop is applied to the skin, and the skin is pricked through the drop. For intradermal testing, a much more dilute solution (e.g., 1:1000 to 1:10,000 w/v) is injected into the skin to observe for a reaction.
Immunotherapy consists of two distinct phases:
Geotrichum candidum extracts may be used in children, provided they are old enough to cooperate with the testing and treatment (usually 5 years and older). Pediatric dosing follows the same weight/volume or PNU titration principles as adult dosing. However, healthcare providers often exercise extreme caution in young children due to the difficulty of monitoring for early signs of systemic reactions. Dose escalations may be more conservative in the pediatric population.
No specific dose adjustments are required for patients with renal impairment, as the proteins are not primarily cleared by the kidneys in a manner that affects systemic toxicity. However, the patient's overall health should be stable.
No dose adjustments are necessary for hepatic impairment, as the extract does not undergo hepatic metabolism via the CYP450 system.
Elderly patients may have a reduced skin response to testing. When used for immunotherapy, the provider must carefully evaluate the patient's cardiovascular status, as the use of epinephrine (the primary treatment for a severe reaction) may be riskier in older adults with underlying heart disease.
Geotrichum candidum extract is never self-administered by the patient at home. It must be administered by a qualified healthcare professional in a clinical setting equipped to handle anaphylaxis.
If a dose of immunotherapy is missed, the next dose may need to be reduced depending on how much time has passed. If more than 2-4 weeks have passed since the last injection, the doctor may revert to a previous lower dose to ensure safety and prevent a reaction.
An "overdose" in the context of allergenic extracts refers to receiving a dose higher than the patient's current tolerance level, which can lead to a severe systemic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular attendance is crucial for the success of immunotherapy.
Most patients receiving Geotrichum candidum extract will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Geotrichum Candidum and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term systemic toxicities associated with Geotrichum candidum extract when used correctly. The primary long-term effect is the desired modulation of the immune system. However, repeated injections over several years can occasionally cause localized thickening of the skin (subcutaneous nodules) at the injection sites. These are generally benign but should be monitored by a physician.
While specific "black box" labels vary by manufacturer, all allergenic extracts, including Geotrichum candidum, carry a general warning regarding the risk of Anaphylaxis.
Report any unusual symptoms to your healthcare provider, especially if they occur after you have left the medical facility.
Geotrichum candidum extract is a potent biological substance. It is intended only for use by physicians specialized in allergy and immunology. Patients must be informed that while immunotherapy can provide long-term relief, it carries an inherent risk of systemic reactions. The safety of the treatment depends heavily on the patient's current health status; for example, if a patient is currently experiencing an asthma flare or a viral infection, the injection should be postponed.
No specific FDA black box warning exists solely for Geotrichum Candidum, but it falls under the mandatory class-wide warnings for all allergenic extracts. The warning states: "Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis and death. Patients should be observed for at least 30 minutes after administration. This product should not be administered to patients with severe or unstable asthma."
Geotrichum candidum extract itself does not typically cause sedation. However, if a patient experiences a systemic reaction or is given an antihistamine to treat a local reaction, they may become drowsy. Patients should ensure they feel completely normal before driving after an injection.
There is no direct chemical interaction between alcohol and Geotrichum candidum extract. However, alcohol consumption can cause vasodilation and may potentially increase the speed of allergen absorption or mask the early symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours before and after an injection.
Immunotherapy is typically a 3-to-5-year commitment. Stopping treatment early may result in the return of allergic symptoms. There is no "withdrawal syndrome" associated with stopping Geotrichum candidum, but the clinical benefits will gradually diminish over time if the maintenance phase is not completed.
> Important: Discuss all your medical conditions with your healthcare provider before starting Geotrichum Candidum. Ensure you have an up-to-date epinephrine auto-injector and know how to use it.
While there are few absolute contraindications for drug combinations, the following should be avoided:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for your safety during immunotherapy.
Geotrichum candidum extract must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to Geotrichum candidum may also show cross-sensitivity to other fungi, such as Galactomyces or certain species of Candida. There is also a known cross-reactivity with certain dairy-derived antigens because the fungus is so prevalent in the dairy environment. If you have a known allergy to Penicillium molds, discuss this with your doctor, as there may be overlapping allergenic proteins.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Geotrichum Candidum. Be honest about your heart health and asthma control.
Geotrichum candidum extract is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
It is not known whether the fungal antigens from Geotrichum candidum are excreted in human milk. However, because these are large proteins that are processed locally in the lymphatic system, it is highly unlikely that significant amounts would reach the breast milk or be absorbed by the nursing infant's gut. The risk to the infant is considered minimal. The decision to continue immunotherapy while breastfeeding should involve a discussion between the patient and their doctor.
There is no evidence that renal impairment alters the response to Geotrichum candidum extract. No dose adjustments are provided in the manufacturer's labeling for patients with kidney disease. However, patients on dialysis should be medically stable before receiving an injection.
Liver disease does not affect the processing of allergenic extracts. No specific adjustments are required for patients with various Child-Pugh scores. The focus remains on the patient's overall stability and ability to tolerate a potential systemic reaction.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health problems.
Geotrichum candidum extract works through two distinct immunological pathways depending on its use:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | N/A (Processed by APCs) |
| Half-life | Days (Immunological signaling) |
| Tmax | 15-30 minutes (Local reaction) |
| Metabolism | Proteolysis (Tissue-based) |
| Excretion | Renal (Minimal as peptides) |
Geotrichum candidum belongs to the Non-Standardized Fungal Allergenic Extract class. Unlike "standardized" extracts (like ragweed or dust mite), which have a proven potency measured in Bioequivalent Allergy Units (BAU), non-standardized extracts are prepared according to consistent manufacturing processes but lack a federally mandated potency assay. Related medications include extracts of Alternaria alternata, Cladosporium, and Aspergillus.
Common questions about Geotrichum Candidum
Geotrichum candidum extract is primarily used for the diagnosis and treatment of mold-related allergies. In a diagnostic setting, it is used in skin prick tests to identify if a patient has an IgE-mediated sensitivity to this specific fungus. If an allergy is confirmed, the extract can be used in allergen immunotherapy, commonly known as allergy shots, to desensitize the patient's immune system. This treatment is intended for patients whose symptoms, such as allergic rhinitis or asthma, are triggered by environmental mold exposure. Additionally, it may be used to evaluate sensitivities to certain fermented foods where this fungus is present.
The most common side effects of Geotrichum candidum extract are localized reactions at the site of the skin test or injection. These include redness, itching, and a raised bump or wheal, which typically appear within minutes and resolve within a few hours. Some patients may also experience mild swelling that lasts for a day or two. Systemic symptoms like tiredness or a slight increase in nasal congestion are less common but can occur. While these local reactions are usually harmless, they must be monitored by a healthcare professional to ensure they do not progress into a more serious systemic reaction.
It is generally recommended to avoid alcohol consumption on the days you receive a Geotrichum candidum injection. Alcohol can cause blood vessels to dilate (expand), which may theoretically increase the rate at which the allergenic extract is absorbed into your bloodstream, potentially increasing the risk of a systemic reaction. Furthermore, alcohol can mask early symptoms of anaphylaxis, such as flushing or dizziness, making it harder for you or your doctor to recognize a medical emergency. To ensure maximum safety during your immunotherapy, it is best to remain sober for at least several hours before and after your appointment. Always discuss your lifestyle habits with your allergist.
Geotrichum candidum is generally not started during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could harm the developing fetus by reducing oxygen supply. However, if a patient is already on a stable maintenance dose of immunotherapy and is tolerating it well, many allergists will choose to continue the treatment. The decision is based on a careful risk-benefit analysis, as stopping treatment might lead to a severe allergy or asthma flare-up, which also carries risks. If you become pregnant while receiving these injections, notify your healthcare provider immediately. They will likely maintain your current dose without further increases until after delivery.
The onset of action for Geotrichum candidum depends on whether it is being used for testing or treatment. For diagnostic skin testing, the results are visible almost immediately, typically within 15 to 20 minutes. For immunotherapy, the process is much slower as it requires the immune system to gradually build up tolerance. Most patients begin to notice a reduction in their allergy symptoms after 6 to 12 months of consistent injections. The full therapeutic benefit is usually reached during the maintenance phase, which can take several years to complete for long-lasting results.
Yes, you can stop taking Geotrichum candidum injections suddenly without experiencing physical withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year course is finished will likely result in the return of your allergy symptoms over time. Immunotherapy works by 'retraining' your immune system, and this process requires long-term consistency to become permanent. If you need to stop treatment due to side effects, financial reasons, or a change in health status, you should discuss a plan with your allergist. They can advise you on the likelihood of your symptoms returning.
If you miss a scheduled immunotherapy dose of Geotrichum candidum, you should contact your allergist's office as soon as possible to reschedule. Missing a dose can affect your progress and, more importantly, your safety. If too much time passes between injections, your immune system's tolerance may decrease, making your next scheduled dose potentially too strong. Depending on the length of the delay, your doctor may need to repeat a previous lower dose or reduce the current dose before resuming the build-up. Never attempt to 'double up' on doses or change your schedule without professional medical guidance.
There is no clinical evidence to suggest that Geotrichum candidum allergenic extract causes weight gain. The extract consists of fungal proteins and stabilizers administered in very small quantities, and it does not affect the metabolic or hormonal systems that regulate body weight. If you experience weight gain while undergoing immunotherapy, it is likely due to other factors, such as the use of oral corticosteroids for asthma management or unrelated lifestyle changes. If you have concerns about weight changes, you should discuss them with your primary care physician to identify the underlying cause.
Geotrichum candidum can be taken alongside many common medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers, as these can make it dangerous to treat an allergic reaction if one occurs. Other medications, like ACE inhibitors and certain antidepressants (MAOIs or TCAs), can also interact with the way your body handles an allergic emergency. While you can continue taking most daily allergy medications like antihistamines during immunotherapy, you must stop them several days before diagnostic skin testing. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and supplements.
Geotrichum candidum is a biological extract rather than a synthetic drug, so the term 'generic' does not apply in the traditional sense. Instead, it is produced by several different biological laboratories as a non-standardized extract. While the core fungal source is the same, products from different manufacturers may have slight variations in their protein concentrations and stabilizers. Because of these variations, allergists generally prefer not to switch between different manufacturers' extracts once a patient has started a treatment course. If a switch is necessary, the doctor will often reduce the dose significantly to ensure safety.